Global Next Generation Cancer Diagnostics Professional Survey Report 2022, Forecast to 2027

Code: RW00014775996
Multimarket Insight
Aug-2022
Life Sciences
137 Pages

More recently, NGS has been adopted in clinical oncology to advance personalized treatment of cancer. NGS is used to identify novel and rare cancer mutations, detect familial cancer mutation carriers, and provide molecular rationale for appropriate targeted therapy.
We aims to provide a complete knowledgeable report so that the readers will benefit from it. The report is properly examined and compiled by industry experts and will shed light on the key information that requires from the clients.

Case numbers are resurging in parts of the world where the COVID-19 pandemic was waning, falling in places that saw huge surges recently, and just beginning to rise in previously little-impacted parts of the globe.
Studying and analyzing the impact of Coronavirus COVID-19 on the Next Generation Cancer Diagnostics industry, the report provide in-depth analysis and professtional advices on how to face the post COIVD-19 period.

Market Segment by Product Type
Next Generation Sequencing
qPCR & Multiplexing
Lab-on- a- chip (LOAC)
Protein Microarrays
DNA Microarrays
Reverse Transcriptase-PCR (RT-PCR)

Market Segment by Product Application
Biomarker Development
CTC Analysis
Proteomic Analysis
Epigenetic Analysis
Genetic Analysis

Finally, the report provides detailed profile and data information analysis of leading company.
Roche Holding Ltd.?Switzerland)
Affymetrix Inc.(US)
Agilent Technologies Inc(Germany)
Abbott Laboratories(US)
QIAGEN N.V.(Germany)
Siemens Healthcare(Germany)
Thermo Fisher Scientific Inc.(US)
Becton Dickinson and Co.(US)
Illumina Inc.(US)
Johnson & Johnson(US)
Allegro Diagnostics Corp.(Brazil)
GE Healthcare(England)
Cepheid Inc.(US)
Life Technologies Corp.(US)
Luminex Corp.(US)

Insights and Tools:
Projected and forecast revenue values are in constant U.S. dollars, unadjusted for inflation.
Product values and regional markets are estimated by market analyst, data analyst and people from related industry, based on companys' revenue and applications market respectively.
The data sources include but not limited to reports of companys,international organizations and governments, MMI market surveys,and related industry news.
Analyses of global market trends, with historical data, estimates for 2022 and projections of compound annual growth rates (CAGRs) through 2027
The market research includes historical and forecast data from like demand, application details, price trends, and company shares by geography, especially focuses on the key regions like United States, European Union, China, and other regions.
In addition, the report provides insight into main drivers,challenges,opportunities and risk of the market and strategies of suppliers. Key players are profiled as well with their market shares in the global market discussed.

Research Objectives
1.To study and analyze the global Next Generation Cancer Diagnostics consumption (value) by key regions/countries, product type and application, history data from 2017 to 2021, and forecast to 2027.
2.To understand the structure of Next Generation Cancer Diagnostics market by identifying its various subsegments.
3.Focuses on the key global Next Generation Cancer Diagnostics manufacturers, to define, describe and analyze the value, market share, market competition landscape, Porter's five forces analysis, SWOT analysis and development plans in next few years.
4.To analyze the Next Generation Cancer Diagnostics with respect to individual growth trends, future prospects, and their contribution to the total market.
5.To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
6.To project the consumption of Next Generation Cancer Diagnostics submarkets, with respect to key regions (along with their respective key countries).
7.To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
8.To strategically profile the key players and comprehensively analyze their growth strategies.

Table of Contents

Global Next Generation Cancer Diagnostics Professional Survey Report Report 2022, Forecast to 2027

1 Market Study Overview
1.1 Study Objectives
1.2 Next Generation Cancer Diagnostics Introduce
1.3 Combined with the Analysis of Macroeconomic Indicators
1.4 Brief Description of Research Methods
1.5 Market Breakdown and Data Triangulation

2 Global Trend Summary
2.1 Next Generation Cancer Diagnostics Segment by Type
2.1.1 Next Generation Sequencing
2.1.2 qPCR & Multiplexing
2.1.3 Lab-on- a- chip (LOAC)
2.1.4 Protein Microarrays
2.1.5 DNA Microarrays
2.1.6 Reverse Transcriptase-PCR (RT-PCR)
2.2 Market Analysis by Application
2.2.1 Biomarker Development
2.2.2 CTC Analysis
2.2.3 Proteomic Analysis
2.2.4 Epigenetic Analysis
2.2.5 Genetic Analysis
2.3 Global Next Generation Cancer Diagnostics Market Comparison by Regions (2017-2027)
2.3.1 Global Next Generation Cancer Diagnostics Market Size (2017-2027)
2.3.2 North America Next Generation Cancer Diagnostics Status and Prospect (2017-2027)
2.3.3 Europe Next Generation Cancer Diagnostics Status and Prospect (2017-2027)
2.3.4 Asia-pacific Next Generation Cancer Diagnostics Status and Prospect (2017-2027)
2.3.5 South America Next Generation Cancer Diagnostics Status and Prospect (2017-2027)
2.3.6 Middle East & Africa Next Generation Cancer Diagnostics Status and Prospect (2017-2027)
2.4 Basic Product Information
2.4.1 Basic Product Information & Technology Development History
2.4.2 Product Manufacturing Process
2.4.3 Interview with Major Market Participants
2.4.4 High-end Market Analysis and Forecast
2.5 Coronavirus Disease 2019 (Covid-19): Next Generation Cancer Diagnostics Industry Impact
2.5.1 Next Generation Cancer Diagnostics Business Impact Assessment - Covid-19
2.5.2 Market Trends and Next Generation Cancer Diagnostics Potential Opportunities in the COVID-19 Landscape
2.5.3 Measures / Proposal against Covid-19

3 Competition by Manufacturer
3.1 Global Next Generation Cancer Diagnostics Sales and Market Share by Manufacturer (2017-2022)
3.2 Global Next Generation Cancer Diagnostics Revenue and Market Share by Manufacturer (2017-2022)
3.3 Global Next Generation Cancer Diagnostics Industry Concentration Ratio (CR5 and HHI)
3.4 Top 5 Next Generation Cancer Diagnostics Manufacturer Market Share
3.5 Top 10 Next Generation Cancer Diagnostics Manufacturer Market Share
3.6 Date of Key Manufacturers Enter into Next Generation Cancer Diagnostics Market
3.7 Key Manufacturers Next Generation Cancer Diagnostics Product Offered
3.8 Mergers & Acquisitions Planning

4 Analysis of Next Generation Cancer Diagnostics Industry Key Manufacturers
4.1 Roche Holding Ltd.?Switzerland)
4.1.1 Company Details
4.1.2 Roche Holding Ltd.?Switzerland) Next Generation Cancer Diagnostics Product Introduction, Application and Specification
4.1.3 Roche Holding Ltd.?Switzerland) Next Generation Cancer Diagnostics Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.1.4 Main Business Overview
4.1.5 Roche Holding Ltd.?Switzerland) News
4.2 Affymetrix Inc.(US)
4.2.1 Company Details
4.2.2 Affymetrix Inc.(US) Next Generation Cancer Diagnostics Product Introduction, Application and Specification
4.2.3 Affymetrix Inc.(US) Next Generation Cancer Diagnostics Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.2.4 Main Business Overview
4.2.5 Affymetrix Inc.(US) News
4.3 Agilent Technologies Inc(Germany)
4.3.1 Company Details
4.3.2 Agilent Technologies Inc(Germany) Next Generation Cancer Diagnostics Product Introduction, Application and Specification
4.3.3 Agilent Technologies Inc(Germany) Next Generation Cancer Diagnostics Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.3.4 Main Business Overview
4.3.5 Agilent Technologies Inc(Germany) News
4.4 Abbott Laboratories(US)
4.4.1 Company Details
4.4.2 Abbott Laboratories(US) Next Generation Cancer Diagnostics Product Introduction, Application and Specification
4.4.3 Abbott Laboratories(US) Next Generation Cancer Diagnostics Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.4.4 Main Business Overview
4.4.5 Abbott Laboratories(US) News
4.5 QIAGEN N.V.(Germany)
4.5.1 Company Details
4.5.2 QIAGEN N.V.(Germany) Next Generation Cancer Diagnostics Product Introduction, Application and Specification
4.5.3 QIAGEN N.V.(Germany) Next Generation Cancer Diagnostics Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.5.4 Main Business Overview
4.5.5 QIAGEN N.V.(Germany) News
4.6 Siemens Healthcare(Germany)
4.6.1 Company Details
4.6.2 Siemens Healthcare(Germany) Next Generation Cancer Diagnostics Product Introduction, Application and Specification
4.6.3 Siemens Healthcare(Germany) Next Generation Cancer Diagnostics Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.6.4 Main Business Overview
4.6.5 Siemens Healthcare(Germany) News
4.7 Thermo Fisher Scientific Inc.(US)
4.7.1 Company Details
4.7.2 Thermo Fisher Scientific Inc.(US) Next Generation Cancer Diagnostics Product Introduction, Application and Specification
4.7.3 Thermo Fisher Scientific Inc.(US) Next Generation Cancer Diagnostics Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.7.4 Main Business Overview
4.7.5 Thermo Fisher Scientific Inc.(US) News
4.8 Becton Dickinson and Co.(US)
4.8.1 Company Details
4.8.2 Becton Dickinson and Co.(US) Next Generation Cancer Diagnostics Product Introduction, Application and Specification
4.8.3 Becton Dickinson and Co.(US) Next Generation Cancer Diagnostics Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.8.4 Main Business Overview
4.8.5 Becton Dickinson and Co.(US) News
4.9 Illumina Inc.(US)
4.9.1 Company Details
4.9.2 Illumina Inc.(US) Next Generation Cancer Diagnostics Product Introduction, Application and Specification
4.9.3 Illumina Inc.(US) Next Generation Cancer Diagnostics Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.9.4 Main Business Overview
4.9.5 Illumina Inc.(US) News
4.10 Johnson & Johnson(US)
4.10.1 Company Details
4.10.2 Johnson & Johnson(US) Next Generation Cancer Diagnostics Product Introduction, Application and Specification
4.10.3 Johnson & Johnson(US) Next Generation Cancer Diagnostics Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.10.4 Main Business Overview
4.10.5 Johnson & Johnson(US) News
4.11 Allegro Diagnostics Corp.(Brazil)
4.11.1 Company Details
4.11.2 Allegro Diagnostics Corp.(Brazil) Next Generation Cancer Diagnostics Product Introduction, Application and Specification
4.11.3 Allegro Diagnostics Corp.(Brazil) Next Generation Cancer Diagnostics Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.11.4 Main Business Overview
4.11.5 Allegro Diagnostics Corp.(Brazil) News
4.12 GE Healthcare(England)
4.12.1 Company Details
4.12.2 GE Healthcare(England) Next Generation Cancer Diagnostics Product Introduction, Application and Specification
4.12.3 GE Healthcare(England) Next Generation Cancer Diagnostics Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.12.4 Main Business Overview
4.12.5 GE Healthcare(England) News
4.13 Cepheid Inc.(US)
4.13.1 Company Details
4.13.2 Cepheid Inc.(US) Next Generation Cancer Diagnostics Product Introduction, Application and Specification
4.13.3 Cepheid Inc.(US) Next Generation Cancer Diagnostics Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.13.4 Main Business Overview
4.13.5 Cepheid Inc.(US) News
4.14 Life Technologies Corp.(US)
4.14.1 Company Details
4.14.2 Life Technologies Corp.(US) Next Generation Cancer Diagnostics Product Introduction, Application and Specification
4.14.3 Life Technologies Corp.(US) Next Generation Cancer Diagnostics Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.14.4 Main Business Overview
4.14.5 Life Technologies Corp.(US) News
4.15 Luminex Corp.(US)
4.15.1 Company Details
4.15.2 Luminex Corp.(US) Next Generation Cancer Diagnostics Product Introduction, Application and Specification
4.15.3 Luminex Corp.(US) Next Generation Cancer Diagnostics Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.15.4 Main Business Overview
4.15.5 Luminex Corp.(US) News

5 Global Next Generation Cancer Diagnostics Sales Categorized by Regions
5.1 Global Next Generation Cancer Diagnostics Revenue, Sales and Market Share by Regions
5.1.1 Global Next Generation Cancer Diagnostics Sales and Market Share by Regions (2017-2022)
5.1.2 Global Next Generation Cancer Diagnostics Revenue and Market Share by Regions (2017-2022)
5.2 North America Next Generation Cancer Diagnostics Sales and Growth Rate (2017-2022)
5.3 Europe Next Generation Cancer Diagnostics Sales and Growth Rate (2017-2022)
5.4 Asia-pacific Next Generation Cancer Diagnostics Sales and Growth Rate (2017-2022)
5.5 South America Next Generation Cancer Diagnostics Sales and Growth Rate (2017-2022)
5.6 Middle East & Africa Next Generation Cancer Diagnostics Sales and Growth Rate (2017-2022)

6 North America Next Generation Cancer Diagnostics Market Size Categorized by Countries
6.1 North America Next Generation Cancer Diagnostics Sales, Revenue and Market Share by Countries
6.1.1 North America Next Generation Cancer Diagnostics Sales (Volume) by Countries (2017-2022)
6.1.2 North America Next Generation Cancer Diagnostics Revenue by Countries (2017-2022)
6.1.3 United States Next Generation Cancer Diagnostics Sales and Growth Rate (2017-2022)
6.1.4 Canada Next Generation Cancer Diagnostics Sales and Growth Rate (2017-2022)
6.1.5 Mexico Next Generation Cancer Diagnostics Sales and Growth Rate (2017-2022)
6.2 North America Next Generation Cancer Diagnostics Revenue (Value) by Manufacturers
6.3 North America Next Generation Cancer Diagnostics Sales and Market Share by Type (2017-2022)
6.4 North America Next Generation Cancer Diagnostics Sales Market Share by Application (2017-2022)

7 Europe Next Generation Cancer Diagnostics Market Size Categorized by Countries
7.1 Europe Next Generation Cancer Diagnostics Sales, Revenue and Market Share by Countries
7.1.1 Europe Next Generation Cancer Diagnostics Sales (Volume) by Countries (2017-2022)
7.1.2 Europe Next Generation Cancer Diagnostics Revenue by Countries (2017-2022)
7.1.3 Germany Next Generation Cancer Diagnostics Sales and Growth Rate (2017-2022)
7.1.4 UK Next Generation Cancer Diagnostics Sales and Growth Rate (2017-2022)
7.1.5 France Next Generation Cancer Diagnostics Sales and Growth Rate (2017-2022)
7.1.6 Russia Next Generation Cancer Diagnostics Sales and Growth Rate (2017-2022)
7.1.7 Italy Next Generation Cancer Diagnostics Sales and Growth Rate (2017-2022)
7.1.8 Spain Next Generation Cancer Diagnostics Sales and Growth Rate (2017-2022)
7.2 Europe Next Generation Cancer Diagnostics Revenue (Value) by Manufacturers
7.3 Europe Next Generation Cancer Diagnostics Sales and Market Share by Type (2017-2022)
7.4 Europe Next Generation Cancer Diagnostics Sales Market Share by Application (2017-2022)

8 Asia-Pacific Next Generation Cancer Diagnostics Market Size Categorized by Countries
8.1 Asia-pacific Next Generation Cancer Diagnostics Sales, Revenue and Market Share by Countries
8.1.1 Asia-pacific Next Generation Cancer Diagnostics Sales (Volume) by Countries (2017-2022)
8.1.2 Asia-pacific Next Generation Cancer Diagnostics Revenue by Countries (2017-2022)
8.1.3 China Next Generation Cancer Diagnostics Sales and Growth Rate (2017-2022)
8.1.4 South Korea Next Generation Cancer Diagnostics Sales and Growth Rate (2017-2022)
8.1.5 Japan Next Generation Cancer Diagnostics Sales and Growth Rate (2017-2022)
8.1.6 Australia Next Generation Cancer Diagnostics Sales and Growth Rate (2017-2022)
8.1.7 India Next Generation Cancer Diagnostics Sales and Growth Rate (2017-2022)
8.1.8 Southeast Asia Next Generation Cancer Diagnostics Sales and Growth Rate (2017-2022)
8.2 Asia-pacific Next Generation Cancer Diagnostics Revenue (Value) by Manufacturers
8.3 Asia-pacific Next Generation Cancer Diagnostics Sales and Market Share by Type (2017-2022)
8.4 Asia-pacific Next Generation Cancer Diagnostics Sales Market Share by Application (2017-2022)

9 South America Next Generation Cancer Diagnostics Market Size Categorized by Countries
9.1 South America Next Generation Cancer Diagnostics Sales, Revenue and Market Share by Countries
9.1.1 South America Next Generation Cancer Diagnostics Sales (Volume) by Countries (2017-2022)
9.1.2 South America Next Generation Cancer Diagnostics Revenue by Countries (2017-2022)
9.1.3 Brazil Next Generation Cancer Diagnostics Sales and Growth Rate (2017-2022)
9.2 South America Next Generation Cancer Diagnostics Sales and Market Share by Type (2017-2022)
9.3 South America Next Generation Cancer Diagnostics Sales Market Share by Application (2017-2022)

10 Middle East and Africa Next Generation Cancer Diagnostics Market Size Categorized by Countries
10.1 Middle East and Africa Next Generation Cancer Diagnostics Sales, Revenue and Market Share by Countries
10.1.1 Middle East and Africa Next Generation Cancer Diagnostics Sales (Volume) by Countries (2017-2022)
10.1.2 Middle East and Africa Next Generation Cancer Diagnostics Revenue by Countries (2017-2022)
10.1.3 GCC Countries Next Generation Cancer Diagnostics Sales and Growth Rate (2017-2022)
10.1.4 Turkey Next Generation Cancer Diagnostics Sales and Growth Rate (2017-2022)
10.1.5 Egypt Next Generation Cancer Diagnostics Sales and Growth Rate (2017-2022)
10.1.6 South America Next Generation Cancer Diagnostics Sales and Growth Rate (2017-2022)
10.2 Middle East and Africa Next Generation Cancer Diagnostics Sales and Market Share by Type
10.3 Middle East and Africa Next Generation Cancer Diagnostics Sales Market Share by Application (2017-2022)

11 Global Next Generation Cancer Diagnostics Market Segment by Type
11.1 Global Next Generation Cancer Diagnostics Revenue, Sales and Market Share by Type (2017-2022)
11.1.1 Global Next Generation Cancer Diagnostics Sales and Market Share by Type (2017-2022)
11.1.2 Global Next Generation Cancer Diagnostics Revenue and Market Share by Type (2017-2022)
11.2 Next Generation Sequencing Sales Growth Rate and Price
11.2.1 Global Next Generation Sequencing Sales Growth Rate (2017-2022)
11.2.2 Global Next Generation Sequencing Price (2017-2022)
11.3 qPCR & Multiplexing Sales Growth Rate and Price
11.3.1 Global qPCR & Multiplexing Sales Growth Rate (2017-2022)
11.3.2 Global qPCR & Multiplexing Price (2017-2022)
11.4 Lab-on- a- chip (LOAC) Sales Growth Rate and Price
11.4.1 Global Lab-on- a- chip (LOAC) Sales Growth Rate (2017-2022)
11.4.2 Global Lab-on- a- chip (LOAC) Price (2017-2022)
11.5.1 Global Protein Microarrays Sales Growth Rate (2017-2022)
11.5.2 Global Protein Microarrays Price (2017-2022)
11.6 DNA Microarrays Sales Growth Rate and Price
11.6.1 Global DNA Microarrays Sales Growth Rate (2017-2022)
11.6.2 Global DNA Microarrays Price (2017-2022)
11.7 Reverse Transcriptase-PCR (RT-PCR) Sales Growth Rate and Price
11.7.1 Global Reverse Transcriptase-PCR (RT-PCR) Sales Growth Rate (2017-2022)
11.7.2 Global Reverse Transcriptase-PCR (RT-PCR) Price (2017-2022)

12 Global Next Generation Cancer Diagnostics Market Segment by Application
12.1 Global Next Generation Cancer Diagnostics Sales Market Share by Application (2017-2022)
12.2 Biomarker Development Sales Growth Rate (2017-2022)
12.3 CTC Analysis Sales Growth Rate (2017-2022)
12.4 Proteomic Analysis Sales Growth Rate (2017-2022)
12.5 Epigenetic Analysis Sales Growth Rate (2017-2022)

13 Global Next Generation Cancer Diagnostics Market Forecast
13.1 Global Next Generation Cancer Diagnostics Revenue, Sales and Growth Rate (2022-2027)
13.2 Next Generation Cancer Diagnostics Market Forecast by Regions (2022-2027)
13.2.1 North America Next Generation Cancer Diagnostics Market Forecast (2022-2027)
13.2.2 Europe Next Generation Cancer Diagnostics Market Forecast (2022-2027)
13.2.3 Asia-Pacific Next Generation Cancer Diagnostics Market Forecast (2022-2027)
13.2.4 South America Next Generation Cancer Diagnostics Market Forecast (2022-2027)
13.2.5 Middle East & Africa Next Generation Cancer Diagnostics Market Forecast (2022-2027)
13.3 Next Generation Cancer Diagnostics Market Forecast by Type (2022-2027)
13.3.1 Global Next Generation Cancer Diagnostics Sales Forecast by Type (2022-2027)
13.3.2 Global Next Generation Cancer Diagnostics Market Share Forecast by Type (2022-2027)
13.4 Next Generation Cancer Diagnostics Market Forecast by Application (2022-2027)
13.4.1 Global Next Generation Cancer Diagnostics Sales Forecast by Application (2022-2027)
13.4.2 Global Next Generation Cancer Diagnostics Market Share Forecast by Application (2022-2027)

14 Market Analysis
14.1.1 Market overview
14.1.2 Market Opportunities
14.1.3 Market Risk
14.1.4 Market Driving Force
14.1.5 Porter's Five Forces Analysis
14.1.6 SWOT Analysis

15 Next Generation Cancer Diagnostics Industry Related Market Analysis
15.1 Upstream Analysis
15.1.1 Macro Analysis of Upstream Markets
15.1.2 Key Players in Upstream Markets
15.1.3 Upstream Market Trend Analysis
15.1.4 Next Generation Cancer Diagnostics Manufacturing Cost Analysis
15.2 Downstream Market Analysis
15.2.1 Macro Analysis of Down Markets
15.2.2 Key Players in Down Markets
15.2.3 Downstream Market Trend Analysis
15.2.4 Sales Channel, Distributors, Traders and Dealers

List of Tables and Figures

Figure Product Picture Next Generation Cancer Diagnostics
Figure Market Concentration Ratio and Market Maturity Analysis of Next Generation Cancer Diagnostics
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Figure Part of Our External Database
Figure Key Executives Interviewed
Table Global Next Generation Cancer Diagnostics Market Size by Type
Figure Global Market Share of Next Generation Cancer Diagnostics by Type in 2021
Figure Next Generation Sequencing Picture
Figure qPCR & Multiplexing Picture
Figure Lab-on- a- chip (LOAC) Picture
Figure Protein Microarrays Picture
Figure DNA Microarrays Picture
Figure Reverse Transcriptase-PCR (RT-PCR) Picture
Table Global Next Generation Cancer Diagnostics Market Size (Volume) by Application
Figure Biomarker Development Picture
Figure CTC Analysis Picture
Figure Proteomic Analysis Picture
Figure Epigenetic Analysis Picture
Figure Genetic Analysis Picture
Table Global Next Generation Cancer Diagnostics Comparison by Regions (M USD) 2017-2027
Figure Global Next Generation Cancer Diagnostics Market Size (Million US$) (2017-2027)
Figure North America Next Generation Cancer Diagnostics Revenue (Million US$) Growth Rate (2017-2027)
Figure Europe Next Generation Cancer Diagnostics Revenue (Million US$) Growth Rate (2017-2027)
Figure Asia-pacific Next Generation Cancer Diagnostics Revenue (Million US$) Growth Rate (2017-2027)
Figure South America Next Generation Cancer Diagnostics Revenue (Million US$) Growth Rate (2017-2027)
Figure Middle East & Africa Next Generation Cancer Diagnostics Revenue (Million US$) Growth Rate (2017-2027)
Table Business Impact Assessment - Covid-19
Table Market Trends and Next Generation Cancer Diagnostics Potential Opportunities in the COVID-19 Landscape
Table Measures / Proposal against Covid-19
Table Global Next Generation Cancer Diagnostics Sales by Manufacturer (2017-2022)
Figure Global Next Generation Cancer Diagnostics Sales Market Share by Manufacturer in 2021
Table Global Next Generation Cancer Diagnostics Revenue by Manufacturer (2017-2022)
Figure Global Next Generation Cancer Diagnostics Revenue Market Share by Manufacturer in 2021
Table Global Next Generation Cancer Diagnostics Manufacturers Market Concentration Ratio (CR5 and HHI)
Figure Top 5 Next Generation Cancer Diagnostics Manufacturer (Revenue) Market Share in 2021
Figure Top 10 Next Generation Cancer Diagnostics Manufacturer (Revenue) Market Share in 2021
Table Date of Key Manufacturers Enter into Next Generation Cancer Diagnostics Market
Table Key Manufacturers Next Generation Cancer Diagnostics Product Type
Table Mergers & Acquisitions Planning
Table Roche Holding Ltd.?Switzerland) Company Profile
Table Next Generation Cancer Diagnostics Product Introduction, Application and Specification of Roche Holding Ltd.?Switzerland)
Table Next Generation Cancer Diagnostics Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Roche Holding Ltd.?Switzerland) 2017-2022
Table Roche Holding Ltd.?Switzerland) Main Business
Table Roche Holding Ltd.?Switzerland) Recent Development
Table Affymetrix Inc.(US) Company Profile
Table Next Generation Cancer Diagnostics Product Introduction, Application and Specification of Affymetrix Inc.(US)
Table Next Generation Cancer Diagnostics Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Affymetrix Inc.(US) 2017-2022
Table Affymetrix Inc.(US) Main Business
Table Affymetrix Inc.(US) Recent Development
Table Agilent Technologies Inc(Germany) Company Profile
Table Next Generation Cancer Diagnostics Product Introduction, Application and Specification of Agilent Technologies Inc(Germany)
Table Next Generation Cancer Diagnostics Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Agilent Technologies Inc(Germany) 2017-2022
Table Agilent Technologies Inc(Germany) Main Business
Table Agilent Technologies Inc(Germany) Recent Development
Table Abbott Laboratories(US) Company Profile
Table Next Generation Cancer Diagnostics Product Introduction, Application and Specification of Abbott Laboratories(US)
Table Next Generation Cancer Diagnostics Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Abbott Laboratories(US) 2017-2022
Table Abbott Laboratories(US) Main Business
Table Abbott Laboratories(US) Recent Development
Table QIAGEN N.V.(Germany) Company Profile
Table Next Generation Cancer Diagnostics Product Introduction, Application and Specification of QIAGEN N.V.(Germany)
Table Next Generation Cancer Diagnostics Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of QIAGEN N.V.(Germany) 2017-2022
Table QIAGEN N.V.(Germany) Main Business
Table QIAGEN N.V.(Germany) Recent Development
Table Siemens Healthcare(Germany) Company Profile
Table Next Generation Cancer Diagnostics Product Introduction, Application and Specification of Siemens Healthcare(Germany)
Table Next Generation Cancer Diagnostics Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Siemens Healthcare(Germany) 2017-2022
Table Siemens Healthcare(Germany) Main Business
Table Siemens Healthcare(Germany) Recent Development
Table Thermo Fisher Scientific Inc.(US) Company Profile
Table Next Generation Cancer Diagnostics Product Introduction, Application and Specification of Thermo Fisher Scientific Inc.(US)
Table Next Generation Cancer Diagnostics Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Thermo Fisher Scientific Inc.(US) 2017-2022
Table Thermo Fisher Scientific Inc.(US) Main Business
Table Thermo Fisher Scientific Inc.(US) Recent Development
Table Becton Dickinson and Co.(US) Company Profile
Table Next Generation Cancer Diagnostics Product Introduction, Application and Specification of Becton Dickinson and Co.(US)
Table Next Generation Cancer Diagnostics Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Becton Dickinson and Co.(US) 2017-2022
Table Becton Dickinson and Co.(US) Main Business
Table Becton Dickinson and Co.(US) Recent Development
Table Illumina Inc.(US) Company Profile
Table Next Generation Cancer Diagnostics Product Introduction, Application and Specification of Illumina Inc.(US)
Table Next Generation Cancer Diagnostics Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Illumina Inc.(US) 2017-2022
Table Illumina Inc.(US) Main Business
Table Illumina Inc.(US) Recent Development
Table Johnson & Johnson(US) Company Profile
Table Next Generation Cancer Diagnostics Product Introduction, Application and Specification of Johnson & Johnson(US)
Table Next Generation Cancer Diagnostics Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Johnson & Johnson(US) 2017-2022
Table Johnson & Johnson(US) Main Business
Table Johnson & Johnson(US) Recent Development
Table Allegro Diagnostics Corp.(Brazil) Company Profile
Table Next Generation Cancer Diagnostics Product Introduction, Application and Specification of Allegro Diagnostics Corp.(Brazil)
Table Next Generation Cancer Diagnostics Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Allegro Diagnostics Corp.(Brazil) 2017-2022
Table Allegro Diagnostics Corp.(Brazil) Main Business
Table Allegro Diagnostics Corp.(Brazil) Recent Development
Table GE Healthcare(England) Company Profile
Table Next Generation Cancer Diagnostics Product Introduction, Application and Specification of GE Healthcare(England)
Table Next Generation Cancer Diagnostics Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of GE Healthcare(England) 2017-2022
Table GE Healthcare(England) Main Business
Table GE Healthcare(England) Recent Development
Table Cepheid Inc.(US) Company Profile
Table Next Generation Cancer Diagnostics Product Introduction, Application and Specification of Cepheid Inc.(US)
Table Next Generation Cancer Diagnostics Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Cepheid Inc.(US) 2017-2022
Table Cepheid Inc.(US) Main Business
Table Cepheid Inc.(US) Recent Development
Table Life Technologies Corp.(US) Company Profile
Table Next Generation Cancer Diagnostics Product Introduction, Application and Specification of Life Technologies Corp.(US)
Table Next Generation Cancer Diagnostics Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Life Technologies Corp.(US) 2017-2022
Table Life Technologies Corp.(US) Main Business
Table Life Technologies Corp.(US) Recent Development
Table Luminex Corp.(US) Company Profile
Table Next Generation Cancer Diagnostics Product Introduction, Application and Specification of Luminex Corp.(US)
Table Next Generation Cancer Diagnostics Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Luminex Corp.(US) 2017-2022
Table Luminex Corp.(US) Main Business
Table Luminex Corp.(US) Recent Development
Figure Global Next Generation Cancer Diagnostics Sales and Growth Rate (2017-2022)
Figure Global Next Generation Cancer Diagnostics Revenue and Growth Rate (2017-2022)
Table Global Next Generation Cancer Diagnostics Sales by Regions (2017-2022)
Figure Global Next Generation Cancer Diagnostics Sales Market Share by Regions in 2021
Table Global Next Generation Cancer Diagnostics Revenue by Regions (2017-2022)
Figure Global Next Generation Cancer Diagnostics Revenue Market Share by Regions in 2021
Figure North America Next Generation Cancer Diagnostics Sales and Growth Rate (2017-2022)
Figure Europe Next Generation Cancer Diagnostics Sales and Growth Rate (2017-2022)
Figure Asia-pacific Next Generation Cancer Diagnostics Sales and Growth Rate (2017-2022)
Figure South America Next Generation Cancer Diagnostics Sales and Growth Rate (2017-2022)
Figure Middle East & Africa Next Generation Cancer Diagnostics Sales and Growth Rate (2017-2022)
Figure North America Next Generation Cancer Diagnostics Revenue and Growth Rate (2017-2022)
Table North America Next Generation Cancer Diagnostics Sales (Volume) by Countries (2017-2022)
Table North America Next Generation Cancer Diagnostics Sales Market Share by Countries (2017-2022)
Figure North America Next Generation Cancer Diagnostics Sales Market Share by Countries in 2021
Table North America Next Generation Cancer Diagnostics Revenue by Countries (2017-2022)
Table North America Next Generation Cancer Diagnostics Revenue Market Share by Countries (2017-2022)
Figure North America Next Generation Cancer Diagnostics Revenue Market Share by Countries in 2021
Figure United States Next Generation Cancer Diagnostics Sales and Growth Rate (2017-2022)
Figure Canada Next Generation Cancer Diagnostics Sales and Growth Rate (2017-2022)
Figure Mexico Next Generation Cancer Diagnostics Sales and Growth Rate (2017-2022)
Table North America Next Generation Cancer Diagnostics Revenue by Manufacturer (2021)
Figure North America Next Generation Cancer Diagnostics Revenue Market Share by Manufacturer in 2021
Table North America Next Generation Cancer Diagnostics Sales by Type (2017-2022)
Table North America Next Generation Cancer Diagnostics Sales Share by Type (2017-2022)
Table North America Next Generation Cancer Diagnostics Sales by Application (2017-2022)
Table North America Next Generation Cancer Diagnostics Sales Share by Application (2017-2022)
Figure Europe Next Generation Cancer Diagnostics Revenue and Growth Rate (2017-2022)
Table Europe Next Generation Cancer Diagnostics Sales (Volume) by Countries (2017-2022)
Table Europe Next Generation Cancer Diagnostics Sales Market Share by Countries (2017-2022)
Figure Europe Next Generation Cancer Diagnostics Sales Market Share by Countries in 2021
Table Europe Next Generation Cancer Diagnostics Revenue by Countries (2017-2022)
Table Europe Next Generation Cancer Diagnostics Revenue Market Share by Countries (2017-2022)
Figure Europe Next Generation Cancer Diagnostics Revenue Market Share by Countries in 2021
Figure Germany Next Generation Cancer Diagnostics Sales and Growth Rate (2017-2022)
Figure UK Next Generation Cancer Diagnostics Sales and Growth Rate (2017-2022)
Figure France Next Generation Cancer Diagnostics Sales and Growth Rate (2017-2022)
Figure Russia Next Generation Cancer Diagnostics Sales and Growth Rate (2017-2022)
Figure Italy Next Generation Cancer Diagnostics Sales and Growth Rate (2017-2022)
Figure Spain Next Generation Cancer Diagnostics Sales and Growth Rate (2017-2022)
Table Europe Next Generation Cancer Diagnostics Revenue by Manufacturer (2021)
Figure Europe Next Generation Cancer Diagnostics Revenue Market Share by Manufacturer in 2021
Table Europe Next Generation Cancer Diagnostics Sales by Type (2017-2022)
Table Europe Next Generation Cancer Diagnostics Sales Share by Type (2017-2022)
Table Europe Next Generation Cancer Diagnostics Sales by Application (2017-2022)
Table Europe Next Generation Cancer Diagnostics Sales Share by Application (2017-2022)
Figure Asia-pacific Next Generation Cancer Diagnostics Revenue and Growth Rate (2017-2022)
Table Asia-pacific Next Generation Cancer Diagnostics Sales (Volume) by Countries (2017-2022)
Table Asia-pacific Next Generation Cancer Diagnostics Sales Market Share by Countries (2017-2022)
Figure Asia-pacific Next Generation Cancer Diagnostics Sales Market Share by Countries in 2021
Table Asia-pacific Next Generation Cancer Diagnostics Revenue by Countries (2017-2022)
Table Asia-pacific Next Generation Cancer Diagnostics Revenue Market Share by Countries (2017-2022)
Figure Asia-pacific Next Generation Cancer Diagnostics Revenue Market Share by Countries in 2021
Figure China Next Generation Cancer Diagnostics Sales and Growth Rate (2017-2022)
Figure South Korea Next Generation Cancer Diagnostics Sales and Growth Rate (2017-2022)
Figure Japan Next Generation Cancer Diagnostics Sales and Growth Rate (2017-2022)
Figure Australia Next Generation Cancer Diagnostics Sales and Growth Rate (2017-2022)
Figure India Next Generation Cancer Diagnostics Sales and Growth Rate (2017-2022)
Figure Southeast Asia Next Generation Cancer Diagnostics Sales and Growth Rate (2017-2022)
Table Asia-pacific Next Generation Cancer Diagnostics Revenue by Manufacturer (2021)
Figure Asia-pacific Next Generation Cancer Diagnostics Revenue Market Share by Manufacturer in 2021
Table Asia-pacific Next Generation Cancer Diagnostics Sales by Type (2017-2022)
Table Asia-pacific Next Generation Cancer Diagnostics Sales Share by Type (2017-2022)
Table Asia-pacific Next Generation Cancer Diagnostics Sales by Application (2017-2022)
Table Asia-pacific Next Generation Cancer Diagnostics Sales Share by Application (2017-2022)
Figure South America Next Generation Cancer Diagnostics Revenue and Growth Rate (2017-2022)
Table South

Roche Holding Ltd.?Switzerland)
Affymetrix Inc.(US)
Agilent Technologies Inc(Germany)
Abbott Laboratories(US)
QIAGEN N.V.(Germany)
Siemens Healthcare(Germany)
Thermo Fisher Scientific Inc.(US)
Becton Dickinson and Co.(US)
Illumina Inc.(US)
Johnson & Johnson(US)
Allegro Diagnostics Corp.(Brazil)
GE Healthcare(England)
Cepheid Inc.(US)
Life Technologies Corp.(US)
Luminex Corp.(US)

First Name *

Last Name

Country *

E-mail *

Contact No *

Company Name*

Job Title*

Comments

Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Have a Question?

EMAIL US

RELATED PRODUCTS

ReportsWeb has an extensive coverage of industry reports, company reports and country reports accross all industries.

View All New Reports

Global Freckle-removing Medical and Beau.. The global market for Freckle-removing Medical and Beauty Eq..

Global Wall Mounted Sinks Market Growth .. The sink is a trough-shaped appliance used to receive kitche..

Global Peripheral Imaging Catheter Marke.. The Peripheral Imaging Catheter's unique design provides exc..

Global Hemostatic Valves and Accessories.. Haemostatic valve prevents blood reflux when a catheter is i..

Global Liver Cancer Treatment Drug Marke.. The global market for Liver Cancer Treatment Drug is estimat..

Global Hypertensive Heart Disease Drug M.. The global market for Hypertensive Heart Disease Drug is est..

Global Urinary Incontinence Drug Market .. The global market for Urinary Incontinence Drug is estimated..

Global Pet Antibiotic Market Growth 2022.. The global market for Pet Antibiotic is estimated to increas..

Global Hemorrhagic Disease Detection Mar.. The global market for Hemorrhagic Disease Detection is estim..

Global Cell Dissociation Solution Market.. The global market for Cell Dissociation Solution is estimate..

Global Cell Detachment and Dissociation .. The global market for Cell Detachment and Dissociation Solut..

Global Cell Detachment Solution Market G.. The global market for Cell Detachment Solution is estimated ..

CUSTOM RESEARCH

ReportsWeb has an extensive coverage of industry reports, company reports and country reports accross all industries.

LEARN MORE